Single Rising Dose Study With Intravenous Infusion and Subcutaneous Injection of BI 1005273 in Healthy Male Volunteers.
Clinical trial NCT01650155 · COMPLETED
Trial details
- NCT number
- NCT01650155
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2014-09-01
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.